Global Chief Scientific & Medical Officer and Director Clinical Research, DKMS; Head, Stem Cell Transplantation Unit
University Hospital Carl Gustav Carus, Dresden, Germany
Prof. Dr Schetelig is the Global Chief Scientific & Medical Officer and Director Clinical Research at DKMS and Head of the Stem Cell Transplantation Unit at University Hospital Carl Gustav Carus, TU Dresden, Germany. A hematologist, transplant physician, and Professor of Stem Cell Transplantation, his work focuses on advancing hematopoietic stem cell transplantation (HSCT), cellular therapies, and international clinical research to improve outcomes for patients with blood cancers and inherited blood disorders.
Professional highlights
- Established the DKMS Clinical Trials Unit in 2013, creating a platform for national and international clinical research in stem cell transplantation and cellular therapies.
- Leads multicentre clinical trials in hematopoietic stem cell transplantation, hematologic malignancies, and inherited blood disorders.
- Contributes to improving donor selection strategies, transplant outcomes, and the development of innovative cellular therapies through evidence-based research.
- Collaborates with international research networks to strengthen clinical evidence and expand access to high-quality transplantation practices.
- Recognized as a leading investigator in stem cell transplantation, advancing research that informs clinical practice and improves patient care globally.